Showing results (1941-1950 of 2,107) with videos related to
Sort By:
Pageof 211
CNS Drugs|December 23, 2015
Carbidopa/Levodopa ER Capsules (Rytary(®), Numient™): A Review in Parkinson's DiseaseSarah L Greig, Kate McKeageCNS Drugs|August 6, 2015
The therapeutic potential of α7 nicotinic acetylcholine receptor (α7 nAChR) agonists for the treatment of the cognitive deficits associated with schizophreniaCorinne Beinat, Samuel D Banister, Marco Herrera, et al.CNS Drugs|August 8, 2015
Intravenous Recombinant Tissue Plasminogen Activator Does Not Impact Mortality in Acute Ischemic Stroke at Any Time Point up to 6 Months: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical TrialsGyanendra Kumar, Drew Uhrig, Susan Fowler, et al.CNS Drugs|August 21, 2015
Propofol: a review of its role in pediatric anesthesia and sedationVidya Chidambaran, Andrew Costandi, Ajay D'MelloCNS Drugs|August 30, 2014
QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive reviewMehrul Hasnain, W Victor R ViewegCNS Drugs|November 14, 2014
Emergency and critical care management of acute ischaemic strokeStephen A Figueroa, Weidan Zhao, Venkatesh AiyagariCNS Drugs|January 15, 2020
Recent Advances in the Treatment of Huntington's Disease: Targeting DNA and RNAKathleen M ShannonCNS Drugs|November 18, 2020
Pharmacological Interactions between the Dual Orexin Receptor Antagonist Daridorexant and Ethanol in a Double-Blind, Randomized, Placebo-Controlled, Double-Dummy, Four-Way Crossover Phase I Study in Healthy SubjectsBenjamin Berger, Sander Brooks, Rob Zuiker, et al.CNS Drugs|November 23, 2020
Three-Year Effectiveness of Dimethyl Fumarate in Multiple Sclerosis: A Prospective Multicenter Real-World StudyBelen Pilo de la Fuente, Julia Sabín, Victoria Galán, et al.CNS Drugs|January 10, 2020
Potential of Glioblastoma-Targeted Chimeric Antigen Receptor (CAR) T-Cell TherapyRyan D Salinas, Joseph S Durgin, Donald M O'RourkePageof 211